Compare Edwards Lifesciences Corporation Common Stock (EW) vs ProShares UltraPro Short QQQ ETF (SQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs ProShares UltraPro Short QQQ ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while ProShares UltraPro Short QQQ ETF trades at $32.67 (market cap $2.12B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 23.3× ProShares UltraPro Short QQQ ETF's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, ProShares UltraPro Short QQQ ETF nearer its low. Which is the better fit depends on your goals.
| EW | SQQQ | |
|---|---|---|
Market Cap | $49.44B | $2.12B |
Volume | 3,508,027 | 42,185,633 |
Sector | Health | Leveraged / Inverse |
52-Week High | $95.18 | $89.43 |
52-Week Low | $72.65 | $31.83 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 12 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SQQQ trades at $32.08, up 0.79% with a bearish technical signal from moving averages but bullish oscillators. The ETF shows oversold conditions with RSI readings below 20, suggesting potential for short-term rebound. Recent news highlights SQQQ's role as a hedging tool against Nasdaq 100 declines, with inverse ETFs potentially benefiting from tech sector weakness.
The outlook remains highly speculative given SQQQ's 3x leveraged inverse structure. While current technical indicators suggest potential for near-term recovery, the ETF faces significant decay risks in sustained bull markets. Investors should weigh hedging benefits against the structural challenges of leveraged inverse products in volatile conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →
